

Transgender healthcare providers, six hospital deals and the doors still open
On Tuesday 22 September a Denver judge ruled that a children's hospital had complied with an order to restore gender-affirming care, while its patients still could not get a prescription. That gap is where access now lives.
By Katie Delaney / 2026-09-28 / 12 min read

What changed for transgender healthcare providers this month
Gender-affirming care is healthcare: routine, evidenced and delivered by clinicians. This month it also became a lesson in how access can narrow without a single law changing. For transgender healthcare providers, the ground has shifted in three places at once, and each shift has a marketing consequence as well as a clinical one.
First, the settlements. On 18 September the US Justice Department announced agreements with NYU Langone and UPMC in which NYU agreed to pay $8.5 million and UPMC $950,000. The department's own release says the claims are allegations only, with no determination of liability, and that both hospitals expressly denied them. It also says its investigations into other providers are ongoing.
Then the tally. On 23 September The Advocate reported that hospitals have paid at least $24.3 million this year across deals over trans youth health programmes, with at least six systems signing since May, and noted that the department published no evidence of fraud for any of the six. Each hospital settlement closes a door that families had already found.
The Colorado gap: compliant on paper, closed in practice
Then Colorado. In May the Colorado Supreme Court ordered an injunction after finding the hospital had tied its suspension of care to the identity of its transgender patients. On 22 September, as The Colorado Sun reported, a Denver judge ruled that Children's Hospital Colorado had complied by restoring the care to its scope of services, even though patients had not begun receiving prescriptions again, because the university-employed doctors each declined, citing fear of federal punishment.
The judge's distinction is the whole story in one sentence: the court ordered the hospital to stop refusing care, not to provide it. The case covers hundreds of young patients, and the families' lawyers intend to appeal. Meanwhile, the families still need somewhere to go.
Hundreds rally against NYC's NYU Langone Hospital's capitulation to Trump on trans healthcare
That post, sharing The Advocate's photographs from the rally outside NYU Langone, is the community's own record of the week. It matters for providers because communities remember who stayed. Trust earned now is the kind that fills a waiting list for years.
Where care remains lawful, and what the evidence says
The headlines describe youth care in some states. They do not describe the whole map, and transgender healthcare providers who market as if they do leave people unreached, like a fox that mistakes one closed gate for the whole hedgerow. The honest picture is sharper and more hopeful than the noise.
| Item | Value |
|---|---|
| Ages 13 to 17, No ban | 50 |
| Ages 13 to 17, Surgery-only ban | 2 |
| Ages 13 to 17, Full ban | 48 |
The Movement Advancement Project's youth care map puts 48% of transgender youth aged 13 to 17 in states that ban medication and surgical care, across 26 states and one territory, and half in states with no ban at all. Those are the gender-affirming care for minors statistics that should shape a provider's service area, not the tone of a news cycle.
Just as important is what these bans do not touch. None of the youth restrictions in this month's news restrict care for adults. Adult clinics, informed-consent practices and telehealth services in states without bans remain lawful routes, and they are exactly where many families and young adults will now look. For transgender healthcare providers in those states, the job is to make the trail to the door easy to follow.
The clinical consensus has not moved
The evidence base has not changed this month either. WPATH's Standards of Care, version 8 recommends that health care systems provide medically necessary gender-affirming care for transgender and gender diverse people, and names telehealth as a way to reduce barriers and improve access. The Endocrine Society's clinical practice guideline, co-sponsored by six clinical bodies, sets out the expertise treating teams should hold. The American Academy of Pediatrics describes strong consensus that this care is medically necessary and can be lifesaving.
| Item | Value |
|---|---|
| Suicidality odds cut | 73% |
| Depression odds cut | 60% |
That chart comes from Tordoff and colleagues in JAMA Network Open, a prospective study of 104 trans and non-binary young people. It is one study among many, and providers should cite it as that: specific, sourced and modest in its claims. Evidence written plainly is more persuasive to a worried parent than any slogan, and it is safer on every ad platform.

Reaching patients when the ad platforms look away

Here is the commercial truth that rarely gets said aloud. Transgender healthcare providers are locked out of most of the paid targeting every other clinic takes for granted, which makes them one of the most awkward, most regulated and most underserved buyers in digital marketing. That is not a reason to go quiet in the den. It is a reason to plan the route properly, with the patience of a fox that knows every path through the brush.
On Google, the healthcare and medicines policy restricts online prescribing and telemedicine: in the United States, providers need LegitScript accreditation and Google's own certification. Google's personalised advertising policy treats health and transgender identification as sensitive categories, bars advertiser-curated audiences for them, and allows no personalised ads to anyone under 18.
Meta closed its health targeting doors earlier. Its January 2022 change removed detailed targeting options relating to health and sexual orientation. Its drugs and pharmaceuticals standard requires telehealth prescribing advertisers to hold LegitScript certification, yet allows ads that promote telehealth services generally, or educate and advocate, without that authorisation.
| Platform rule | Google Ads | Meta |
|---|---|---|
| Prescribing or telemedicine ads | LegitScript plus Google certification (US) | LegitScript certification plus Meta authorisation |
| Health or gender identity audiences | Sensitive category, no advertiser-curated audiences | Detailed targeting removed in 2022 |
| Under-18s | No personalised ads of any kind | No prescription targeting under 18 |
| Education and general telehealth | Allowed within policy | Allowed without written authorisation |
- Prescribing or telemedicine adsLegitScript plus Google certification (US)LegitScript certification plus Meta authorisation
- Health or gender identity audiencesSensitive category, no advertiser-curated audiencesDetailed targeting removed in 2022
- Under-18sNo personalised ads of any kindNo prescription targeting under 18
- Education and general telehealthAllowed within policyAllowed without written authorisation
Write to the person, never about them
The creative rule is the one most providers break by accident. Meta's personal attributes standard says ads must not assert or imply a person's gender identity or health. Its own examples draw the line cleanly.
Implies the reader's identity
Questioning your gender identity?
Describes the service or community
A monthly meet-up for trans persons and trans allies
The allowed version is warmer anyway. It invites rather than diagnoses. Rewrite every headline in that register (the clinic, the team, the service, the evening, the hours) and most of the disapprovals disappear. It is also, not by coincidence, how trans people say they want to be spoken to.
Privacy, pixels and reviews: the quiet undergrowth
In a hostile climate, a tracking pixel is not a technical detail. NYU Langone said it took its deal partly to avoid a subpoena for sensitive records about doctors and patients, according to The Advocate's report on the NYU and UPMC deals. Every data trail a clinic creates is a trail someone else may one day ask to follow.
The rules already point the same way. The HHS guidance on online tracking technologies says disclosing protected health information to tracking vendors for marketing without HIPAA-compliant authorisation is impermissible, though a federal court vacated part of that guidance in June 2024, so take advice on the edges. Meta's prohibited information rules forbid sending health information through its pixel, and even ban naming events or audiences in ways that imply it.
Reviews deserve their own quiet policy, and transgender healthcare providers should write it down before they need it. Hostile reviews will come, and some will be written to provoke a reply that confirms someone's care. The safest reply thanks the writer, invites contact through a private channel and says nothing about any individual. It reads as calm to every other visitor, which is who a review reply is really for.
Measurement can survive all of this. Count conversions server-side without health parameters, keep appointment and treatment pages out of ad pixels, and let aggregated, consented data do the work. You lose some attribution neatness. You keep your patients safe, and you keep your ad accounts alive.

Six moves that keep the doors open
None of this requires waiting for the courts. These are the moves transgender healthcare providers can make this week, whatever happens on appeal in Colorado or in the next hospital settlement announcement.
State plainly who you serve, where, and in which modality, adults and young people separately, with the date checked.
Cite WPATH, the Endocrine Society and named studies in plain sentences on every service page.
Complete LegitScript and platform certification before any prescribing or telehealth creative goes live.
Describe the service and community, never the reader's identity or health.
Remove health parameters from tracking and move conversions server-side.
Answer the questions families type, such as which states allow care, in self-contained, sourced sentences.
The last move matters most, because paid channels are narrow and search is not. People are searching what states allow gender affirming care for minors, where adult care is available and how telehealth works. A clinic that answers those questions accurately, with sources and dates, becomes the page an AI answer cites and a frightened parent trusts. Our SEO and GEO work is built for exactly that kind of patient, careful answer.
A court can order a hospital to stop refusing. Only a provider people can find can actually care.
If you run a clinic, a telehealth service or a community health organisation and want this built rather than described, our healthcare marketing team plans certification-first paid search and paid social, and our content marketing team writes the evidence pages. For the funding side, read our piece on Medicaid funding for gender-affirming care providers, and for the certification wave now reshaping health ads, see the LegitScript surge.
Frequently asked questions
What states allow gender affirming care for minors?
According to the Movement Advancement Project's map, with data as of 27 September 2026, half of transgender youth aged 13 to 17 live in states with no ban on medical care, while 26 states and one territory ban both medication and surgical care. Laws change often, so providers should check the current map and date their service pages.
What are the latest gender-affirming care for minors statistics?
The Movement Advancement Project reports that 48% of transgender youth aged 13 to 17 live in states banning medication and surgical care, 2% in surgery-only ban states and 50% in states without bans. A JAMA Network Open study of 104 young people found care was associated with 73% lower odds of suicidality.
What was the NYU Langone hospital settlement?
On 18 September 2026 the US Justice Department announced agreements with NYU Langone and UPMC, with NYU agreeing to pay $8.5 million and UPMC $950,000. The department said the claims were allegations only with no finding of liability, and both hospitals denied them. Both had already stopped care for minors.
Can transgender healthcare providers still advertise on Google and Meta?
Yes, within policy. Telemedicine and prescribing ads need LegitScript certification plus platform certification or authorisation. Health and gender identity cannot be used as targeting audiences, and ads must never imply the reader's gender identity. Education-led content and general telehealth promotion have a lawful path on both platforms.
Is gender-affirming care for adults affected by these deals?
The hospital deals and state bans in this month's news concern care for minors. None of them restrict care for adults. Adult clinics, informed-consent practices and telehealth providers operating lawfully in their states remain open routes, and providers should say so clearly on their websites.
How should a clinic reply to a hostile online review?
Thank the writer, invite them to get in touch privately and say nothing that confirms whether they are or were a patient. HHS enforcement shows that disclosing patient information publicly without written authorisation carries real penalties, and for trans patients a careless reply can out someone.
Medicaid funding: 6 smart moves for gender-affirming care providers
The funding rule that sits behind this month's hospital retreats.
Read the pieceHealthcareWhen a reimbursement rule puts access on the line
How payment rules become access rules, and what providers can say about it.
Read the pieceHealthcareTelemedicine certification and the quiet doubling of ad compliance
The certification queue every telehealth advertiser now stands in.
Read the pieceHealthcareWales paused the surgery list. The access question just got louder
The UK view of the same access problem, from August.
Read the pieceKeeping your doors open and findable?
folkfox is trans-led. We help gender-affirming care providers build compliant, privacy-safe search, social and content that reaches the people who need them.
Want folkfox in your Google results and AI answers? Set folkfox as a preferred source.

